Revive Therapeutics Ltd. RVVTF

RVVTF Company Overview

Revive Therapeutics Ltd. is a Canadian life sciences company focused on drug development and commercialization across biotechnology, pharmaceuticals, and mental health therapeutics, with an emphasis on infectious diseases and psychedelic-assisted therapies. The company’s activities center on identifying, developing, and repurposing novel and existing drug candidates for unmet medical needs, particularly in areas with limited effective treatments.

Revive’s primary revenue drivers are research and development programs rather than product sales, as the company remains in the clinical and pre-commercial stages. Its strategy emphasizes rapid development pathways through drug repurposing and regulatory efficiency. The company was founded in 2018 and initially focused on cannabinoid-based therapeutics before expanding into psychedelic compounds and infectious disease treatments, most notably during the COVID‑19 pandemic.